Breakdown | |||||
TTM | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 |
---|---|---|---|---|---|
Income Statement | Total Revenue | ||||
1.66B | 1.68B | 1.61B | 1.34B | 1.19B | 1.24B | Gross Profit |
319.40M | 1.28B | 576.70M | 492.30M | 398.50M | 433.80M | EBIT |
306.30M | 298.40M | 314.80M | 319.70M | 242.50M | 253.60M | EBITDA |
376.50M | 390.60M | 402.10M | 392.00M | 324.30M | 316.70M | Net Income Common Stockholders |
191.90M | 183.60M | 224.70M | 234.60M | 173.60M | 166.60M |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | ||||
187.10M | 359.70M | 328.90M | 274.60M | 246.20M | 330.60M | Total Assets |
1.55B | 2.71B | 2.78B | 1.86B | 1.74B | 1.86B | Total Debt |
422.90M | 1.12B | 1.08B | 465.20M | 509.10M | 664.70M | Net Debt |
235.80M | 763.40M | 755.60M | 190.60M | 262.90M | 334.10M | Total Liabilities |
786.90M | 1.55B | 1.62B | 853.20M | 889.10M | 1.03B | Stockholders Equity |
765.80M | 1.16B | 1.17B | 1.01B | 851.30M | 825.30M |
Cash Flow | Free Cash Flow | ||||
197.70M | 193.20M | 113.70M | 204.20M | 202.40M | 159.50M | Operating Cash Flow |
285.70M | 298.60M | 231.20M | 268.30M | 252.00M | 221.90M | Investing Cash Flow |
-87.50M | -95.70M | -576.60M | -62.10M | -52.50M | -176.90M | Financing Cash Flow |
-240.50M | -219.20M | 362.20M | -204.80M | -143.90M | -50.50M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
75 Outperform | £6.00B | 19.99 | 13.99% | 2.46% | 6.10% | 33.05% | |
74 Outperform | £4.28B | 17.56 | 23.50% | 1.73% | 0.64% | 4.92% | |
69 Neutral | £5.29B | 16.94 | 17.83% | 1.88% | -4.95% | 36.95% | |
66 Neutral | £4.26B | 22.28 | 16.16% | 2.79% | -1.03% | 4.13% | |
66 Neutral | £2.04B | 4.20 | 21.80% | 6.31% | -15.51% | 200.70% | |
63 Neutral | £3.85B | 24.26 | 6.84% | 3.96% | -3.92% | -7.32% | |
62 Neutral | $7.25B | 12.39 | 3.08% | 3.39% | 3.63% | -14.32% |
Spirax Sarco Engineering has announced the vesting and sale of shares by key managerial personnel under the Spirax Sarco Performance Share Plan (2022 Award). The transactions, conducted on the London Stock Exchange, involve the Group CEO and other directors, reflecting the company’s ongoing commitment to aligning managerial interests with shareholder value.
Spirax Sarco Engineering announced the award of shares to several key executives under the Spirax-Sarco Performance Share Plan (PSP) for 2025, which will vest in 2028 subject to performance conditions. This move signifies a strategic effort to align the interests of its leadership with the company’s long-term performance goals, potentially impacting its operational focus and stakeholder value.
Spirax Group PLC, a UK-based company, has announced a change in major holdings due to the acquisition or disposal of financial instruments by Eleva Capital SAS, a Paris-registered entity. This notification indicates that Eleva Capital SAS now holds a total of 3.08% of voting rights in Spirax Group, with 2.05% attached to shares and 1.03% through financial instruments. This adjustment in holdings reflects Eleva Capital’s strategic positioning and potential influence within the company, impacting Spirax Group’s shareholder dynamics.
Spirax Group plc has announced a proposed final dividend of 117.5 pence per share for 2024, subject to shareholder approval, marking an increase from the previous year. This announcement reflects the company’s ongoing commitment to delivering value to its shareholders and maintaining a strong financial position. The total dividend for the year amounts to 165.0 pence per share, indicating a positive financial performance. The dividend is scheduled to be paid on 23 May 2025 to shareholders on the register by 25 April 2025, highlighting the company’s stable and promising outlook.
Spirax Group plc reported its 2024 full-year results, highlighting a 4% organic revenue growth despite challenging global industrial production conditions. The company achieved a 7% increase in statutory operating profit and improved profit margins, driven by operational improvements and strategic investments. Spirax Group’s restructuring efforts are expected to yield significant benefits for future growth, with a focus on maintaining organic sales growth ahead of industrial production in 2025. The company’s strategic initiatives, including the Together for Growth Strategy, aim to position Spirax Group for long-term growth opportunities while simplifying operations and leveraging resources effectively.
Spirax Group plc has announced transactions related to its employee share schemes, in compliance with the UK Market Abuse Regulation. The transactions involve the acquisition and award of shares under the company’s Share Incentive Plan, impacting key executives including the Group CEO, HR Director, Sustainability Director, and Managing Director. These transactions are part of the company’s efforts to align management interests with shareholder value, potentially enhancing stakeholder confidence.
Spirax Group plc has announced transactions related to its employee share schemes as per UK Market Abuse Regulation. This includes acquisitions and awards under the Share Incentive Plan involving key company executives. The transactions reflect a structured approach to managing share distributions within the company, potentially reinforcing stakeholder confidence and aligning managerial interests with shareholder value.
Spirax Group has announced the appointment of Maria Antoniou as an Independent Non-Executive Board Director and Chair of the Remuneration Committee, effective from June 2025. Maria, who brings extensive international HR experience from her role at Morgan Advanced Materials and previous senior roles at large organizations, will succeed Jane Kingston. This appointment is part of Spirax Group’s succession planning efforts to support its Together for Growth Strategy. The transition highlights Spirax’s focus on strategic growth and sustainable development, aligning with their goal to enhance stakeholder value and operational excellence.
Spirax Group plc has announced recent transactions related to its employee share schemes in compliance with the UK Market Abuse Regulation. The transactions involve acquisitions and awards of shares to key executives, including the Group Chief Executive Officer, Group HR Director, Group Sustainability Director, and interim directors, highlighting the company’s ongoing commitment to employee incentives and shareholder value.